Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone beta-Lactamase Inhibitor

导出原文传递

翻译打印收藏纠错

作者： Ambrose, Paul G. ^[1] ; VanScoy, Brian D. ^[2] ; Trang, Michael ; McCauley-Miller, Jennifer ; Conde, Haley ; Bhavnani, Sujata M. ; Alexander, Dylan C. ; Friedrich, Lawrence V.

作者单位： Merck & Co Inc, Kenilworth, NJ USA ^[1] Inst Clin Pharmacodynam, Schenectady, NY 12305 USA ^[2]

关键词 beta-lactamase inhibitor CB-618 pharmacokinetics-pharmacodynamics

发布时间 2018-07-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Antimicrobial agents and chemotherapy.

2017年61卷12期

e00630-e00630页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone beta-Lactamase Inhibitor

Antimicrobial agents and chemotherapy.

相似文献

Antimicrobial agents and chemotherapy.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone beta-Lactamase Inhibitor

Antimicrobial agents and chemotherapy.

相似文献

Antimicrobial agents and chemotherapy.

相关期刊

检索历史清除